[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
From The Medical Letter on Drugs and Therapeutics
April NaN, 2014

Deep Brain Stimulation for Parkinson’s Disease With Early Motor Complications

JAMA. 2014;311(16):1686-1687. doi:10.1001/jama.2014.3323

Deep brain stimulation is FDA-approved and has been used for years to treat patients with advanced Parkinson’s disease (PD) who have severe levodopa-induced motor complications.1 New evidence from a controlled trial suggests that it may also be effective for patients with PD and early motor complications.

Medical therapy is effective for initial treatment of PD.2 Surgical ablation or deep brain stimulation has generally been recommended only for patients with intolerable dyskinesias or motor fluctuations while on levodopa. Appropriate candidates for surgery are those whose cognition is relatively intact, who are not depressed, and who have no medical contraindications.3

First Page Preview View Large
First page PDF preview
First page PDF preview